Showing 14,241 - 14,260 results of 106,674 for search '(( 50 ((mean decrease) OR (we decrease)) ) OR ( 5 ((step decrease) OR (a decrease)) ))', query time: 1.54s Refine Results
  1. 14241
  2. 14242
  3. 14243
  4. 14244
  5. 14245
  6. 14246
  7. 14247
  8. 14248
  9. 14249
  10. 14250
  11. 14251
  12. 14252
  13. 14253
  14. 14254
  15. 14255
  16. 14256

    The numerical solution of model (1) for infected compartment vs. time with different scenarios of Phase 6 in the First Case: 1<sup><i>st</i></sup> scenario, no lockdown is implemen... by Sara K. Al-Harbi (12418482)

    Published 2022
    “…<p>The numerical solution of model <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0265779#pone.0265779.e002" target="_blank">(1)</a> for infected compartment vs. time with different scenarios of Phase 6 in the First Case: 1<sup><i>st</i></sup> scenario, no lockdown is implemented; 2<sup><i>nd</i></sup> scenario, no lockdown while <i>SD</i> increases; 3<sup><i>rd</i></sup> scenario, lockdown increases; 4<sup><i>th</i></sup> scenario, <i>SD</i> increases; 5<sup><i>th</i></sup> scenario, lockdown decreases; 6<sup><i>th</i></sup> scenario, <i>SD</i> decreases; 7<sup><i>th</i></sup> scenario, lockdown and <i>SD</i> increases; 8<sup><i>th</i></sup> scenario, lockdown decreases and <i>SD</i> increases; 9<sup><i>th</i></sup> scenario, <i>ρ</i> is the same as in Phase 5; 10<sup><i>th</i></sup> scenario, <i>ρ</i> is the same as in Phase 5 while <i>SD</i> increases.…”
  17. 14257

    Supplementary Material for: Severe Pulmonary Hypertension Associated with COPD: Hemodynamic Improvement with Specific Therapy by Girard A. (4154179)

    Published 2015
    “…First-line treatments were endothelin receptor antagonists in 11 patients, phosphodiesterase-5 inhibitors in 11 patients, calcium blocker in 1 patient, combination therapy in 3 patients including 2 with a prostanoid. …”
  18. 14258

    Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A<sub>2A</sub> and dopamine D<sub>2</sub> receptors for Parkinson's disease treatment - Fig 5 by Yi-Ming Shao (577266)

    Published 2018
    “…<p>Dose-response curves of compound <b>5</b> (A), compound <b>6</b> (B) and (±)-PPHT.HCl (C) in D<sub>2</sub>R-proteopolymersomes-based fluorescence polarisation (FP) competition assay with BODIPY-NAPS. …”
  19. 14259

    Table1_Case Report: Chanarin-Dorfman Syndrome: A Novel Homozygous Mutation in ABHD5 Gene in a Chinese Case and Genotype-Phenotype Correlation Analysis.xlsx by Bo Liang (450389)

    Published 2022
    “…<p>The Chanarin–Dorfman syndrome (CDS) is a rare, autosomal recessively inherited genetic disease, whch is associated with a decrease in the lipolysis activity in multiple tissue cells. …”
  20. 14260

    Chronic Exposure to Perfluorooctane Sulfonate Induces Behavior Defects and Neurotoxicity through Oxidative Damages, <i>In Vivo</i> and <i>In Vitro</i> by Na Chen (153323)

    Published 2014
    “…Using green fluorescent protein (GFP) labelled transgenic strains, we found that PFOS caused down-regulated expression of a chemoreceptor gene, <i>gcy-5</i>, in ASE chemosensory neurons, but did not affect cholinergic neurons and dopaminergic neurons. …”